AEHR(AEHR)
AEHR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $126M | $211M | $276M | $196M |
| Low | $123M | $207M | $270M | $192M |
| High | $129M | $216M | $282M | $201M |
| EBITDA Avg | $10M | $16M | $21M | $15M |
| Low | $9M | $16M | $21M | $15M |
| High | $10M | $17M | $22M | $15M |
| EBIT Avg | $7M | $12M | $16M | $12M |
| Low | $7M | $12M | $16M | $11M |
| High | $8M | $13M | $17M | $12M |
| Net Income Avg | $19M | $43M | $70M | $35M |
| Low | $19M | $41M | $68M | $34M |
| High | $20M | $44M | $72M | $36M |
| EPS Avg | $0.63 | $1.38 | $2.27 | $1.14 |
| Low | $0.61 | $1.35 | $2.21 | $1.11 |
| High | $0.65 | $1.43 | $2.34 | $1.18 |
| Analysts (Rev / EPS) | 1 / 2 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $27M | $37M | $34M | $38M |
| Low | $26M | $35M | $32M | $36M |
| High | $28M | $38M | $35M | $40M |
| EBITDA Avg | $2M | $3M | $3M | $3M |
| Low | $2M | $3M | $2M | $3M |
| High | $2M | $3M | $3M | $3M |
| EBIT Avg | $2M | $2M | $2M | $2M |
| Low | $2M | $2M | $2M | $2M |
| High | $2M | $2M | $2M | $2M |
| Net Income Avg | $3M | $6M | $6M | $8M |
| Low | $3M | $6M | $6M | $7M |
| High | $3M | $7M | $6M | $8M |
| EPS Avg | $0.10 | $0.20 | $0.20 | $0.25 |
| Low | $0.10 | $0.19 | $0.18 | $0.24 |
| High | $0.11 | $0.22 | $0.21 | $0.27 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 1 | 1 / 1 | 1 / 1 |